Philadelphia Pharmaceuticals Company (ASE:PHIL)
Jordan flag Jordan · Delayed Price · Currency is JOD
1.550
0.00 (0.00%)
At close: Feb 25, 2026

Philadelphia Pharmaceuticals Company Company Description

Philadelphia Pharmaceuticals Company develops, manufactures, and markets human pharmaceutical products, cosmetics, and medical devices of various therapeutic categories in Jordan.

The company provides products for skin related disorders, including anti-lice and scabicides preparations, antiseptics and disinfectants, bleaching and hyperpigmentation disorders preparations, emollients and protectives, keratolytics/topical psoriasis treatment preparations, and skin healing agents, as well as agents for dermatitis; and topical acne preparation, anti-pruritic, anti-viral, plain antifungal and anti-infective, plain steroid, steroids with antifungal/anti-infective combination, and skin recoloring products.

It also offers products for women health, such as vaginal antifungals, alkalinizing and cleansing agents, antimicrobials, germicidal fungicidal, antiseptics and hemostatic, and vaginal progesterone; and products in the areas of alimentary, gastrointestinal system, anti-inflammatory, analgesic, antipyretic, dental-oropharyngeal, hair care, local anesthetics, and respiratory system, as well as supplements and health care-OTC products, and hemorroidal and anal fissure preparations.

The company provides spray, nasal spray, and ointment. It also exports its products in the Middle East and North Africa region.

The company was founded in 1993 and is headquartered in Amman, Jordan.

Philadelphia Pharmaceuticals Company
Country Jordan
Founded 1993
Industry Pharmaceutical Preparations
Employees 129
CEO Jamal Ishaq Abu Al Hawa

Contact Details

Address:
Azadi Complex
Amman
Jordan
Phone 962 6 4200507
Website philapharma.com

Stock Details

Ticker Symbol PHIL
Exchange Amman Stock Exchange
Fiscal Year January - December
Reporting Currency JOD
SIC Code 2834

Key Executives

Name Position
Jamal Ishaq Abu Al Hawa Chief Executive Officer
Belal Abdujabbar Salameh Chief Financial Officer